AstraZeneca’s COVID-19 vaccine has virtually the same rate of effectiveness in keeping people alive and out of hospital as the rival Pfizer jab.

The federal government’s chief infectious disease modeller said on Tuesday the Oxford University-developed vaccine was on par with Pfizer when combating the aggressive delta strain, and a dramatic increase in take-up among over-40s is needed to end the virus risk in Australia.